Colgate-Palmolive (India) standalone net profit declines 11.91% in the June 2025 quarter
Net profit of Colgate-Palmolive (India) declined 11.91% to Rs 320.62 crore in the quarter ended June 2025 as against Rs 363.98 crore during the previous quarter ended June 2024. Sales declined 4.38% to Rs 1420.64 crore in the quarter ended June 2025 as against Rs 1485.76 crore during the previous quarter ended June 2024. Particulars Quarter Ended Jun. 2025 Jun. 2024 % Var. Sales 1420.641485.76 -4 OPM % 31.8634.21 - PBDT 469.49530.76 -12 PBT 431.95489.25 -12 NP 320.62363.98 -12
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indian Express
9 minutes ago
- Indian Express
Tata Sons-backed Tata Capital Ltd files for IPO
Tata Sons-backed non-banking financial company (NBFC), Tata Capital Ltd, filed draft papers on Monday for an initial public offering (IPO). Tata Capital's IPO consists of a combination of fresh issuance and an offer for sale (OFS), amounting to approximately 47.58 crore equity shares. The company will be issuing up to 21 crore new shares and the existing shareholders are looking to offload up to 26.58 crore shares. Tata Sons Private Ltd, the promoter of the company, is planning to sell up to 23 crore shares in the IPO, while International Finance Corporation (IFC) has proposed to sell up to 3.58 crore shares. The issue size is estimated at around Rs 17,000 crore, as per Prime Database. The shares will be issued at a face value of Rs 10 per share. The company will use the proceeds from the fresh issue to augment its tier-1 capital base to meet its future capital requirement, including onward lending. Tata Capital is the third largest diversified NBFC in the country. The Reserve Bank of India has classified it as a systemically important NBFC, which requires stricter regulatory adherence. As per the RBI regulations, Tata Capital is required to be listed by the end of September. Tata Capital, the flagship financial services company of the Tata Group, is a subsidiary of Tata Sons Private Limited. It is primarily engaged in the lending business which comprises retail finance, SME finance and corporate finance. Tata Capital's consolidated book size increased to Rs 2,21,950.37 crore as at March 31, 2025 from Rs 1,57,760.55 crore as at March 31, 2024. During FY25, it recorded consolidated total income of Rs 28,369.87 crore as against Rs 18,198.38 crore in FY24, an increase of about 55.89 per cent. On a standalone basis, Tata Capital's recorded gross income of Rs 21,940.08 crore in FY2024-25, compared to Rs 13,309.11 crore in FY24. Profit after tax during the year was Rs 2,594.28 crore as against Rs 2,492.45 crore.
&w=3840&q=100)
Business Standard
9 minutes ago
- Business Standard
Aurobindo Pharma Q1 PAT falls 10% on drop in API sales, US market revenue
Aurobindo Pharma on Monday reported a 10.2% year-on-year (Y-o-Y) drop in consolidated profit after tax (PAT) for the June quarter (Q1 FY26), which stood at Rs 824 crore. The decline was attributed to a drop in sales in its active pharmaceutical ingredients (API) business and the United States (US) market. The Hyderabad-based drugmaker had recorded a net profit of Rs 918 crore in Q1 FY25. The company stated that its API business was affected by pricing pressures and geopolitical tensions, with revenues for the segment falling by 16% Y-o-Y to Rs 916 crore in Q1 FY26. However, the drugmaker recorded a 4% Y-o-Y rise in revenue from operations, reaching Rs 7,868 crore in the June quarter, up from Rs 7,567 crore in Q1 FY25. This increase was primarily driven by a 7.4% Y-o-Y rise in the drugmaker's formulations business revenue, which contributes around 85% of the company's overall revenue. Aurobindo Pharma saw an 18% Y-o-Y revenue growth in European markets, which stood at Rs 2,338 crore, driven by a strong performance across all key markets. Similarly, revenue from growth markets formulations increased by 8.8% Y-o-Y to Rs 772 crore in the June quarter, compared to Rs 709 crore in the same period last year. However, the company's US formulations business, which accounts for 44% of its revenue, saw a marginal 1.9% Y-o-Y dip in sales, from Rs 3,555 crore in Q1 FY25 to Rs 3,488 crore in Q1 FY26. According to the company's regulatory filing, the decline in US revenue was primarily due to a significant reduction in sales of the anti-cancer medication lenalidomide. Commenting on the company's performance, K. Nithyananda Reddy, Vice Chairman and Managing Director of Aurobindo Pharma, said that the company has started FY26 steadily, with its European business maintaining strong growth momentum and the core US business showing resilience despite temporary challenges from destocking and seasonal dynamics. The company announced its results after market hours. On Monday, Aurobindo Pharma's shares rose marginally by 1.04%, ending the day's trade at Rs 1,090.90 apiece on the exchanges.
Economic Times
11 minutes ago
- Economic Times
Richer than Ambani! Noida man gets Rs 10,01,35,60,00,00,00,00,00,01,00,23,56,00,00,00,00,299 in dead mother's Kotak savings account
A 20-year-old man in Noida discovered an unfathomable ₹1 septillion trillion in his Kotak Mahindra Bank account, prompting an Income Tax Department investigation. The account, belonging to Deepak, was frozen after the suspicious deposit was flagged. Authorities are probing whether it was a technical error, glitch, or money laundering attempt. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads In a strange turn of events, a 20-year-old man from Noida , Uttar Pradesh, was stunned to find an astronomical sum—over ₹1 septillion trillion or 1 undecillion—credited to his Kotak Mahindra Bank savings total amount in question is in 37 digits - Rs 10,01,35,60,00,00,00,00,00,01,00,23,56,00,00,00,00,299.A journalist, Sachin Gupta, tweeted this earlier today. According to the tweet, the 20-year-old Deepak got this amount though he said it is about 1 billion 13 lakh 56 thousand crore rupees."My math is a bit weak. The rest of you can do the multiplication and division. Currently, the Income Tax Department is investigating. The bank account has been frozen," read the per a report of News24, the 20-year-old was operating the account which originally belonged to his mother, Gayatri Devi, who passed away two months ago. On the night of August 3, Deepak received a notification showing a credit of ₹1.13 lakh crore (₹1,13,56,000 crore). Confused and alarmed, he shared the message with his friends, asking them to count the next morning, Deepak went to the bank to verify the transaction. Bank officials confirmed the mind-boggling balance but informed him that the account had been frozen due to the suspiciously large deposit. The matter was immediately flagged to the Income Tax Department, which has now launched a formal the news spread rapidly, Deepak was bombarded with calls from relatives, friends, and neighbors. Unable to handle the sudden attention, he switched off his are now investigating whether the transaction was a technical error, a banking glitch , or a possible case of money laundering. Officials say the true source of the funds will be known only after a thorough expressed their disbelief. One wrote, "Not possible. It is just an error in the bank's software or a manual entry mistake."Another quipped that the 20-year-old is now richer than person even tried to count the amount, saying, "One hundred quintillion, one hundred thirty-five quadrillion, six hundred trillion, ten million, twenty-three thousand, five hundred sixty, and two hundred ninety-nine."
